PRINCETON, N.J., Aug. 20 -- Ranbaxy Pharmaceuticals, a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that RLL has received approval from the U.S. Food and Drug ...

The good news for Sun Pharma is that it's closed the books on one more legal problem it inherited from its Ranbaxy Laboratories buyout eight years ago. The bad: It's going to cost the generics maker ...

Ranbaxy Laboratories Signs A New R&D Agreement With GlaxoSmithKline; Ranbaxy Could Receive Over $100 Million PRINCETON, N.J., Feb. 6 -- Ranbaxy Laboratories Limited (Ranbaxy) announced today that the ...

MUMBAI (Reuters) - Drugmaker Ranbaxy Laboratories Ltd (RANB.NS), which has agreed to be acquired by Sun Pharmaceutical Industries Ltd (SUN.NS) for $3.2 billion, posted a loss in the March quarter, hit ...

WASHINGTON/MUMBAI (Reuters) - Ranbaxy Laboratories Ltd (RANB.NS) has received approval from the U.S. Food and Drug Administration (FDA) to launch a cheaper copy of Novartis AG's blood pressure pill ...

Daiichi Sankyo claimed it had been deceived when its venture into Indian generic drug manufacturing turned into a regulatory maelstrom that eventually led it to unload Ranbaxy Laboratories at a loss.

An India-based generic drug giant, Ranbaxy Laboratories, will pay Oregon $2.3 million after last year admitting to crimes involving the selling of substandard medicines. Though officials say the ...

Ranbaxy, a subsidiary of Ranbaxy Laboratories Ltd., India's biggest drugmaker, is operating under increased scrutiny from the U.S. Food and Drug Administration because of quality lapses at multiple ...

India’s Sun Pharmaceutical Industries is buying troubled generic drug maker Ranbaxy Laboratories in a $4-billion deal, the companies said Monday. The combined company will be India’s biggest ...

MUMBAI, Dec 1 (Reuters) - Ranbaxy Laboratories said on Thursday it has launched the first generic version of the cholesterol-lowering Lipitor in the U.S., the largest selling drug of all time, sending ...

Sun Pharma signs binding term sheet to settle class actions Proposed settlement comes ahead of an April 5 trial (Reuters) - Sun Pharmaceutical Industries Ltd on Wednesday said it had agreed to pay ...

The proposed sale of Ranbaxy Laboratories to Sun Pharmaceutical closes a troubled chapter for the Indian generic drug maker's owner, Japan's Daiichi Sankyo. If the deal is successful, Sun and Ranbaxy ...